Daewoong pharmaceutical

069620.KO

124.64 USD

2.25

+1.84%

Overview

Last close

124.64 usd

Market cap

1.43B usd

52 week high

124.64 usd

52 week low

72.15 usd

Target price

144.56 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

1.3688

Price/Book Value

2.3984

Enterprise Value

1.83B usd

EV/Revenue

1.7479

EV/EBITDA

15.4162

Key financials

Revenue TTM

1.05B usd

Gross Profit TTM

543.55M usd

EBITDA TTM

162.77M usd

Earnings per Share

N/A usd

Dividend

0.41 usd

Total assets

1.61B usd

Net debt

418.75M usd

About

Daewoong Pharmaceutical Co., Ltd. develops, manufactures and commercializes pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. The company was founded in 1945 and is headquartered in Seoul, South Korea.